Himplasia (tablet)
Total no. of papers:11 - Clinical Papers:10, Experimental Papers:1
(Research papers based on Indications)
Benign prostatic hyperplasia
- Clinical evaluation of Himplasia in the management of benign prostate hyperplasia.
Vijay N. Agarwal, M.D., M.C.h. (Urol), Ex-Associate Professor Urology, Government Medical College, Surat, Gujrat, India, Priyanka Agarwal, M.S., Consultant Surgeon, Surat, Gujrat, India,
Pralhad S. Patki, M.D., Head-Medical Services & Clinical Trials, R&D Center, The Himalaya Drug Company, Bengaluru, India. Indian Medical Journal, 2010; 104(1): 20
- Evaluation of clinical efficacy and safety of Himplasia in BPH: A prospective, randomized, placebo-controlled, double blind, phase III clinical trial
Dr. Pranjal R. Modi1, DNB (Urology) and Dr. S.A. Kolhapure2*, MD.
1Department of Urology and Transplantation Surgery, Institute of Kidney Diseases & Research Centre, BJ Medical College & Civil Hospital, Ahmedabad, India,
2Senior Medical Advisor, R&D Center, The Himalaya Drug Company, Bengaluru, India, Medicine Update 2004: 12(6), 33.
- Evaluation of the efficacy and safety of Himplasia in BPH: A randomised, double-blind, placebo-controlled, phase III clinical trial
Dr. Saswata Chakraborty, M.S.1, Dr. Dilip Karamakar, M.S., M.Ch.2, Dr. S.A. Kolhapure, M.D.,3*
1Research Assistant, 2Professor & Head, Department of Urology, Calcutta National Medical College & Hospital, Kolkata, India. 3Senior Medical Advisor, R&D Center, The Himalaya Drug Company, Bengaluru, India, Medicine Update (2004): 12(4), 39.
- Evaluating the Efficacy and Safety of Himplasia (PC-27) in the Medical Management of Benign Prostatic Hyperplasia
Ketan Shukla, Consultant Urologist & Transplant Surgeon, Sterling Hospital, Behind Drive-in Cinema, Ahmedabad, India, and Kolhapure, S.A., R&D Center, The Himalaya Drug Company, Bengaluru, Karnataka, India, Indian Journal of Clinical Practice (2004): April issue.
- Clinical evaluation of Himplasia in benign prostatic hyperplasia: An open clinical trial
Manoranjan Sahu, Ramesh Bhat, P., Department of Shalya Shalakya, Sir Sundarlal Hospital, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India, and Kala Suhas Kulkarni, R&D Center, The Himalaya Drug Company, Bengaluru, India, Medicine Update (2003): (11), 1, 75.
- Double-blind placebo-controlled study of PR-2000 in the management of benign prostatic hyperplasia
Garg, S.K., M.S., D.N.B. (Surgery), M.Ch., D.N.B. (Urology) Bombay, Urologist and Transplant Surgeon, Garg Urological Clinic, B-51, Brij Enclave Colony, Varanasi-221 005, Uttar Pradesh, India, and
Kala Suhas Kulkarni*, M.D., Medical Advisor, R&D Center, The Himalaya Drug Company, Makali, Bengaluru, India, The Antiseptic (2002): (99), 1, 8.
- Use of PR-2000, a herbal formulation in the medical management of benign prostatic hyperplasia
Shukla, G.N., Medical Superintendent & Professor of Surgery, C.U. Shah Medical College, Dudhrej Road, Surendranagar-363 001. Gujarat, India, and Mahender Nayak, Senior Executive - R&D Center, The Himalaya Drug Company, Bengaluru, India, Indian Journal of Clinical Practice (2002): (13), 2, 53.
- A study of Prostane in the treatment of benign prostatic hyperplasia
Lokesh Upadhyay and Tripathi, K., Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India, Phytotherapy Research (2001): (15), 411. - Efficacy and safety of a herbal preparation PR-2000 in the treatment of symptomatic benign prostatic hyperplasia
Sahu, M., Reader and Head, Department of Shalaya Shalakya, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India,
and Vijay Kumar, V., M.B.B.S., Clinical Research Associate, R&D Center, The Himalaya Drug Company, Makali, Bengaluru, India, JAMA India - The Physicians' Update (2001): 4 (12), 43.
- Efficacy and safety of 'Prostane' in the management of symptomatic benign prostatic hyperplasia: A clinical evaluation
Singh, K.M., M.S., F.I.C.S., F.A.C.S., M.N.M.S., Head, Department of Urology, King George's Medical College, Lucknow, India, JAMA India - The Physicians' Update (2001): (4), 11, 43.